baber/WOPTO huggingface dataset:
Patent JP-3043075-B2 (JP)
IPC: B21B1/46
Filed: 1996-07-26
Granted: 2000-05-22
Abstract: PCT No. PCT/DE96/01441 Sec. 371 Date Apr. 2, 1998 Sec. 102(e) Date Apr. 2, 1998 PCT Filed Jul. 26, 1996 PCT Pub. No. WO97/04891 PCT Pub. Date Feb. 13, 1997A process for operating a continuous casting plant with a continuous casting machine that has a stationary mold and is connected via a roller table to an equalizing furnace. After establishment of the slab format at the mold outlet, at least the casting parameter of casting speed is set so that the slab, upon entry into the equalizing furnace, has the desired roll temperature of the hot strip to be produced, and the lowest point of the liquid pool is always located in the mouth region of the continuous casting machine. Measures are taken to influence the heat energy content of the slab after it leaves the continuous casting machine.
Patent JP-H087147-B2 (JP)
IPC: G01N33/52
Filed: 1991-03-27
Abstract: A method for determining the amount of an analyte in a sample fluid utilizing an assay element which comprises at least one reagent layer. The assay method includes the steps of optically reading a signal producing species, e.g., a fluorescent label, a first time prior to depositing the sample fluid on the assay element and a second time, at the same wavelength and in the same location within the assay element after the sample fluid has been applied to the assay element and the sample analyte has interacted with the reagent(s) present in the assay element. The first, or dry, reading is corrected for relative humidity and/or temperature variations.
Patent JP-H0832638-B2 (JP)
IPC: A61K47/48
Filed: 1990-05-24
Abstract: An adjuvant composition, comprising a metabolizable oil and an emulsifying agent, wherein the oil and the detergent are present in the form of an oil-in-water emulsion having oil droplets substantially all of which are less than 1 micron in diameter. In preferred embodiments, the emulsifying agent is also an immunostimulating agent, such as a lipophilic muramyl peptide. Alternatively, an immunostimulating agent separate from the emulsifying agent can be used.
Patent JP-2781068-B2 (JP)
IPC: B21D39/10
Filed: 1994-09-12
Granted: 1998-07-30
Abstract: A swaging unit (12) which is portable and which has a locking fitting to co-operate with separable components (22,23) to secure a sleeve (11) in an engagement with the swaging unit. In this manner, a tube (10) can be swaged onto the sleeve. The locking fitting has internal threads (29) which engage with external threads (27) on the separable components to facilitate engagement. The swaging unit can be finely adjusted by having fine threads (52) between a locknut (45) and a cage (20) for housing the mandrel (13).
Patent JP-4201834-B2 (JP)
IPC: C12N1/20
Filed: 1996-08-16
Granted: 2008-12-24
Abstract: The present invention relates to a process for separating polyhydroxyalkanoate (PHA) from a biomass comprising the PHA, the process comprising: (a) treating the biomass with a PHA solvent and a marginal nonsolvent for PHA; (b) removing any insoluble biomass, thereby leaving behind a solution of PHA and marginal nonsolvent for PHA; and (c) removing the PHA solvent from the solution, thereby resulting in a suspension of precipitated PHA in the marginal nonsolvent for PHA. Optionally, the process further comprises removing the marginal nonsolvent for PHA, thereby leaving behind the PHA. The present invention further relates to the suspension and the PHA produced by the process.
Patent JP-3040479-B2 (JP)
IPC: B43L1/12
Filed: 1994-11-01
Granted: 2000-05-15
Abstract: PCT No. PCT/GB94/02391 Sec. 371 Date Apr. 30, 1996 Sec. 102(e) Date Apr. 30, 1996 PCT Filed Nov. 1, 1994 PCT Pub. No. WO95/12489 PCT Pub. Date May 11, 1995A polymeric film having a translucent first layer of polymeric material, a transparent second layer of polymeric material on at least one surface of the first layer, and an adherent layer comprising an acrylic resin on the surface of the second layer remote from the first layer is disclosed. Both the first and second layers are preferably formed of biaxially oriented polyethylene terephthalate. The first layer contains an inorganic filler opacifying agent. The polymeric film is particularly suitable for use as an upper sheet in a re-usable label employing the "magic slate" principle.
Patent JP-3251287-B2 (JP)
IPC: A61K33/24
Filed: 1991-08-02
Granted: 2002-01-28
Abstract: Nutritional mineral supplements comprising calcium citrate malate and salts of manganese, copper and zinc are disclosed. These supplements, which provide at least 25% RDA of the minerals, and used in addition to the normal diet. These supplements are useful for increasing bone growth and for treating age-related bone loss in humans and animals.
Patent JP-3038014-B2 (JP)
IPC: E04H1/12
Filed: 1995-10-26
Granted: 2000-05-08
Abstract: PCT No. PCT/EP95/04214 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed Oct. 26, 1995 PCT Pub. No. WO96/15344 PCT Pub. Date May 23, 1996A support structure for architectural systems is suggested which comprises a plurality of supports (2) standing on a base and serving to bear a load. The supports (2) are constituted by air-tight hollow bodies (6) which possesses a wall of flexible material and are charged with compressed air in order to have a rigid form.
Patent JP-2810546-B2 (JP)
IPC: F01M11/03
Filed: 1995-01-12
Granted: 1998-10-15
Abstract: A heat exchanger is disclosed for automotive lubricants and coolants wherein the heat exchanger has a calibrated bypass orifice located therein to maintain the flow therethrough at all times, particularly during cold flow operation, or high pressure transient conditions such as at engine start-up. The heat exchanger has a housing defining a fluid inlet chamber and a fluid outlet chamber. A separator is located between the inlet and outlet chambers and heat exchange passages are located between and communicate with the inlet and outlet chambers. The separator has a calibrated bypass orifice therethrough for the continuous flow of fluid between the inlet and outlet chambers bypassing the heat exchange passages.
Patent JP-3688722-B2 (JP)
IPC: A61F2/14
Filed: 1998-05-21
Granted: 2005-08-31
Abstract: A kit comprising a plurality of implants for implanting together into tunnels or pockets formed within the tissue of the sclera of an eye for increasing the effective working distance of the eye.
Patent JP-3578457-B2 (JP)
IPC: G16H30/20
Filed: 1994-03-17
Granted: 2004-10-20
Abstract: A system for acquiring images during a medical procedure and using the acquired images includes a storage device for storing, for each one of a plurality of users of the system, or for each one of a plurality of medical procedures, or for each one of a plurality of input or output devices, information that indicates one or more processing operations to be performed on images obtained by an input device. A system processor responds to an identity the user who is currently using the system by performing processing operations on the obtained images and applying the images to an output device based on the stored information that corresponds to the current user.
Patent JP-3040170-B2 (JP)
IPC: B41N10/02
Filed: 1995-02-28
Granted: 2000-05-08
Abstract: A printing article which includes a rotatable metal support in the form of a cylinder and a compressible laminate mounted upon the support. The compressible laminate has upper and lower surfaces and a substantially uniform thickness and includes a printing face which forms the upper surface and a compressible layer positioned beneath the printing face. The upper surface of the compressible layer is spaced closer to the upper surface of the printing face in the center of the cylindrical support than at the ends. Preferably, this laminate is cylindrical and is in the form of a printing blanket or printing roll. The invention also relates to a method for forming the compressible laminate.
Patent ES-2392998-B2 (ES)
Title: Procedimiento para la reducción catalítica de compuestos nitroaromáticos.
Inventor: SANZ DIEZ ROBERTO
IPC: C07C209/34
Filed: 2011-05-30
Granted: 2013-07-17
Abstract: La presente invención se refiere a un procedimiento para la reducción catalítica de compuestos orgánicos que incluyen un grupo funcional nitro a compuestos que incluyen un grupo funcional amino mediante la utilización de pinacol (2,3-dimetil-2,3-butanodiol) como agente reductor en presencia de un catalizador de molibdeno (VI), en un disolvente orgánico, a presión atmosférica o superior y a una temperatura entre 110-150ºC, generando como principales subproductos agua y acetona.
Patent AU-2001255680-B2 (AU)
Title: Guaifenesin sustained release formulation and tablets
Inventor: KEYSER DONALD J
IPC: A61K47/18
Filed: 2001-04-26
Granted: 2006-02-16
Abstract: The invention relates to a modified release pharmaceutical product having two portions, wherein a first portion comprises a first quantity of guaifenesin and a first pharmaceutical additive in an immediate release formulation, wherein the first quantity of guaifenesin becomes fully bioavailable in the subject's stomach, and a second portion comprises a second quantity of guaifenesin and a second pharmaceutical additive in a sustained release formulation, wherein the ratio of said first quantity to said second quantity provides a C max  in a human subject equivalent to the C max  obtained when the first of three doses of a standard immediate release formulation having one third of a total amount of guaifenesin in the modified release product is dosed every four hours over a 12 hour period, wherein said product also provides therapeutically effective bioavailability for at least twelve hours after a single dose in a human subject according to serum analysis, and wherein the total amount of guaifenesin in the modified release product is from 600 mg to 1200 mg.
Patent AU-2003237771-B2 (AU)
Title: Hearing aid
Inventor: ABEL ERIC
IPC: A61F11/00
Filed: 2003-01-24
Granted: 2008-05-15
Abstract: The present invention relates to a hearing aid system comprising a hearing implant and a method of powering a hearing implant, the system comprising an external ear canal module and an implant, wherein the signalling and/or powering of the ear implant is by way of a light signal being provided to the implant through the ear drum from, for example, the ear canal module.
Patent AU-2003249819-B2 (AU)
Title: Warp triplet composite forming fabric
Inventor: STONE RICHARD
IPC: D21F1/00
Filed: 2003-07-22
Granted: 2006-05-11
Abstract: A forming fabric having a paper side layer and a machine side layer comprises a first set of paper side layer wefts, a second set of machine side layer wefts and a single set of warp yarn triplets. In the fabric weave pattern, each member of each triplet set of warp yarns interweaves with the paper side weft yarns to occupy in sequence segments of an unbroken warp path in the paper side surface, and each triplet in each set of warp yarns interlaces alone with at least one single machine side layer weft yarn. Each segment in the unbroken warp path is separated by at least one paper side layer weft yarn. The machine side layer interlacing points are regularly spaced. After heat setting, the fabrics typically have an air permeability typically from about 7,500 to about 10,500 m<SUP>3</SUP>/m<SUP>2</SUP>/hr. Paper products made using these fabrics have enhanced printability.
Patent AU-2003291586-B2 (AU)
Title: Permselective membrane and process for manufacturing thereof
Inventor: GOHL HERMANN
IPC: B01D69/08
Filed: 2003-12-17
Granted: 2008-11-13
Abstract: A method for preparing by solvent phase inversion spinning a hollow fiber membrane suitable for dialysis. The membrane includes at least one hydrophobic polymer and at least one hydrophilic polymer. An outer surface of the membrane is characterized by pores having sizes in the range of 0.5-3 μm, with the density of the pores on the outer surface of the membrane being in the range of 10,000 to 150,000 pores per mm2. The method includes dissolving the at least one hydrophobic polymer and the at least one hydrophilic polymer in at least one solvent to form a polymer solution, extruding the thus-formed polymer solution through an outer ring slit of a nozzle with two concentric openings, extruding a center fluid through the inner opening of the nozzle, and wishing said membrane. The polymer solution coming out through the outer slit opening on the outside of the precipitating fiber is exposed to a humid steam/air mixture including a solvent content of between 0.5 and 10% by weight related to the water content.
Patent AU-2004204815-B2 (AU)
Title: Method for in vivo regulation of cardiac muscle contractility
Inventor: GIORDANO FRANK
IPC: A61K38/00
Filed: 2004-01-12
Granted: 2010-03-11
Abstract: A method for regulating in vivo calcium transport in cardiac muscle of animals suffering from congestive heart failure is disclosed. According to the method, calcium ATPase activity (which decreases as congestive heart failure develops) and cardiac muscle contractility augmented by delivering a gene which operatively encodes the enzyme into the heart. Delivery systems, including but not limited to using adeno-associated viral vectors are provided. Methods for monitoring the expression and effect of the gene product on cardiac performance are also provided.
Patent AU-2004212166-B2 (AU)
Title: 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
Inventor: SCHEEL-KRUGER JORGEN
IPC: C07D451/02
Filed: 2004-02-10
Granted: 2010-07-29
Abstract: This invention relates to novel 8-aza-bicyclop[3.2.1]octane derivatives useful as monoamine neurotransmitter re-up-take inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
Patent AU-2004270149-B2 (AU)
Title: Articulating suturing device and method
Inventor: LASSER AMELIA
IPC: A61B17/00
Filed: 2004-08-12
Granted: 2010-05-27
Abstract: Devices, systems, and methods for suturing of body lumens allow the suturing of vascular puncture sites located at the distal end of a percutaneous tissue tract. An elongated articulated foot is inserted through a penetration and actuated extend the foot carrying suturing attachment cuffs. Needles are advanced from the shaft through the vessel wall outside of the penetration and into engagement with the needle cuffs after the foot has been drawn proximally up against the endothelial surface of the blood vessel. The cuffs lockingly engage the needles and can be withdrawn along the needle paths and through the tissue tract to form a loop of suture across the puncture. The articulating foot may be realigned with the shaft and withdrawn proximally through the tissue tract without dilating the tissue tract.
Patent AU-2005209637-B2 (AU)
Title: Affinity selected signature peptides for protein identification and quantification
Inventor: ZHANG XIANG
IPC: G01N33/68
Filed: 2005-09-09
Granted: 2008-06-12
Abstract: A method for protein identification in complex mixtures that utilizes affinity selection of constituent proteolytic peptide fragments unique to a protein analyte. These “signature peptides” function as analytical surrogates. Mass spectrometric analysis of the proteolyzed mixture permits identification of a protein in a complex sample without purifying the protein or obtaining its composite peptide signature.
Patent AU-2005259729-B2 (AU)
Title: Skin plate adhesive product and method for its manufacture
Inventor: LYKKE MADS
IPC: A61F13/02
Filed: 2005-06-30
Granted: 2010-12-16
Abstract: A skin plate product is provided, which can be better tailored with respect to controlling the properties of the first and second surfaces by cutting holes in an adhesive matrix with a laser and subsequently filling these holes with a second material. Preferably at least one zone of the second material extends from the top surface to the bottom surface of the adhesive, with an exposed part of the second material at the top surface having a different pattern than an exposed part of the second material at the bottom surface. The zones are formed as bodies of frustums of cones having their basis at the same surface.
Patent AU-2005265033-B2 (AU)
Title: Evoked response testing system for neurological disorders
Inventor: FADEM KALFORD C
IPC: A61B5/00
Filed: 2005-06-16
Granted: 2011-08-04
Abstract: A dyslexia screening system suitable for clinical use includes an integrated headset (10) that efficiently and conveniently performs an auditory evoked response (ERP) test by positioning electrodes (16) about the ears of the subject. An integral control module (12) automatically performs the test, providing simplified controls and indications to the clinician. A number of screening tests that are stored in the headset are periodically uploaded for billing, remote analysis and result reporting. A paradigm that characterizes testing performed for a subject along with the patient identification and/or patient demographics are stored in an associated fashion for later fusion and analyses with similar but not necessarily identically constructed ERP tests.
Patent AU-2005265150-B2 (AU)
Title: C-MET kinase binding proteins
Inventor: ALBA BENJAMIN M
IPC: A61K38/00
Filed: 2005-06-17
Granted: 2012-04-12
Abstract: Polypeptides comprising monomer domains that bind to c-MET, or portions thereof, are provided.
Patent AU-2005284684-B2 (AU)
Title: Heat exchanger improvements
Inventor: AITKEN JOHN DAVID
IPC: F24D3/08
Filed: 2005-09-14
Granted: 2011-07-21
Abstract: A heat exchanger having one or more of a device for supplying fluid to the cavity, a connector or a heat storage element. The fluid supplying device is formed from a housing defining a cavity, a pipe for connecting the cavity to an inlet, a valve for selectively opening the inlet, a float for actuating the valve in accordance with the level of fluid in the heat exchanger cavity. The connector includes a pipe, having an end piece that is urged against an inner surface of the heat exchanger cavity thereby causing a lug to be embedded in the wall, with a gasket resting against the inner surface to create a seal. The heat storage has a housing formed from an elongate body and two end caps that contains a phase change material selected in accordance with an intended operating temperature of the heat storage element.
Patent AU-2006244478-B2 (AU)
Title: Ultrasonic aerosol generator
Inventor: WATANABE WIWIK S
IPC: B05B17/06
Filed: 2006-05-05
Granted: 2012-09-13
Abstract: An ultrasonic aerosol generator for delivering a liquid formulation in an aerosolized form at a high output rate of greater than 0.5 mL/minute, preferably greater than 1.0 mL/minute, and with diameters in a respirable size range, methods of using this device and kits including the device are described herein. The ultrasonic aerosol generator (10) contains at least (a) a liquid reservoir/aerosolization chamber (11), (b) a piezoelectric engine (12), (c) a relief aperture (13), and (d) an aerosol delivery element (20). Preferably the aerosolized particles that are delivered to the user through the aerosol delivery element have an average aerodynamic diameter of between 1 and 20 μm, more preferably between 1 and 10 μm, and most preferably between 1 and 5 μm. Optionally, the ultrasonic aerosol generator is designed to deliver more than one formulation simultaneously, preferably a low cost and/or stable formulation is administered simultaneously with a more expensive and/or labile formulation. In the preferred embodiment, the ultrasonic aerosol generator is a hand-held device designed for a single user.
Patent AU-2006253089-B2 (AU)
Title: Dual television tuner
Inventor: PIN POO TENG
IPC: H04N5/46
Filed: 2006-06-01
Granted: 2011-06-23
Abstract: A dual television tuner having a television tuner module and a wireless local area network module both operatively connected to an antenna for receiving a television signal from the antenna, and for passing the television signal for playing on a host to which the dual television tuner is able to be operatively connected.
Patent AU-2006256791-B2 (AU)
Title: Polypeptides having antimicrobial activity and polynucleotides encoding same
Inventor: VIND JESPER
IPC: A23K20/195
Filed: 2006-06-02
Granted: 2012-01-19
Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
Patent AU-2006267338-B2 (AU)
Title: Heterocycle-substituted benzimidazole derivative
Inventor: OGINO YOSHIO
IPC: A61K31/497
Filed: 2006-07-12
Granted: 2012-08-16
Abstract: A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: (I) wherein X to X independently represent a carbon atom or the like; the ring A represents a 5- to 6-membered heteroaryl having 1 to 4 heteroatoms independently selected from the group consisting of a nitrogen atom, a sulfur atom and an oxygen atom; X represents an oxygen atom or the like; X represents a carbon atom or the like; Het represents a 5- or 6-membered aliphatic heterocycle; R represents an aryl or the like; R represents a formyl group or the like; and R represents a -C alkyl or the like. The compound or salt has a glucokinase activation effect and is useful as a therapeutic agent for diabetes.
Patent AU-2006286346-B2 (AU)
Title: Quality controlled artificial eyelashes extension system
Inventor: SOPHY MERSZEI
IPC: G06Q99/00
Filed: 2006-05-17
Granted: 2011-11-24
Abstract: The present invention is a quality controlled artificial eyelashes extension system having two main features. One is the method and materials for the application of artificial lash hairs onto existing natural eyelashes of a human subject to extend the length of the natural eyelash. This feature provides the training and materials to attach the eyelash extensions on a hair-by hair basis to a subject's existing natural eyelash. The second is the quality control feature of the present lash extension system which provides for assuring that practitioners of the system are appropriately trained, and the consumable materials utilized by the system are safe for human use. Quality control assurance of practitioners and consumable materials is accomplished by having programs for practitioner training and certification, and for materials quality assurance which controls the quality of the system's consumable materials made available to practitioners.
Patent AU-2006331363-B2 (AU)
Title: Aryl-isoxazol-4-yl-imidazo[1, 5-a]pyridine derivatives
Inventor: HAN BO
IPC: A61K31/437
Filed: 2006-12-18
Granted: 2012-07-05
Abstract: The present invention is concerned with aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives of formula (I) wherein: R is hydrogen, halogen, hydroxy, lower alkyl, benzyloxy or -O-(CH)-(CO)-5 or 6 membered heteroaryl optionally substituted by aryl and lower alkyl; R is hydrogen, lower alkyl, or -(CO)-R; R is hydrogen, halogen, cyano, lower alkyl, or -(CO)-R; R is hydroxy, lower alkoxy, NR'R'', wherein R' and R'' are each independently hydrogen, cycloalkyl, 5 or 6-membered heterocycloalkyl or lower alkyl optionally substituted by cycloalkyl, cyano, 5 or 6-membered heterocycloalkyl or 5 or 6-membered heteroaryl; as well as pharmaceutically acceptable acid addition salts thereof. It has been found that this class of compounds show high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.